Whittier Trust Co. Increases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Whittier Trust Co. increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 23.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,469 shares of the biotechnology company’s stock after buying an additional 3,649 shares during the quarter. Whittier Trust Co.’s holdings in Axon Enterprise were worth $11,571,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Natixis Advisors LLC raised its stake in shares of Axon Enterprise by 5.4% during the 3rd quarter. Natixis Advisors LLC now owns 30,392 shares of the biotechnology company’s stock valued at $12,145,000 after buying an additional 1,552 shares during the last quarter. Fifth Third Wealth Advisors LLC lifted its holdings in Axon Enterprise by 35.4% in the third quarter. Fifth Third Wealth Advisors LLC now owns 1,082 shares of the biotechnology company’s stock valued at $432,000 after acquiring an additional 283 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Axon Enterprise in the 3rd quarter worth approximately $2,162,000. PNC Financial Services Group Inc. boosted its position in Axon Enterprise by 17.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company’s stock worth $2,249,000 after purchasing an additional 840 shares in the last quarter. Finally, Avior Wealth Management LLC increased its holdings in shares of Axon Enterprise by 3.0% during the 3rd quarter. Avior Wealth Management LLC now owns 2,995 shares of the biotechnology company’s stock valued at $1,197,000 after purchasing an additional 86 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Down 1.7 %

Shares of AXON opened at $558.41 on Friday. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The stock has a market cap of $42.79 billion, a PE ratio of 144.29, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm’s fifty day moving average is $592.10 and its two-hundred day moving average is $539.60. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent analyst reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.